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Summary
Wegener's granulomatosis (WG) is a form of
systemic vasculitis which, although well studied,
still constitutes a black box with respect to its
pathogenesis and -physiology. The complexity
of the disease is partly due to the fact that
autoimmune phenomen4 among which the most
characteristic is the presence ofautoantibodies to
neutrophil enzymes (ANCA), can be observed
alongside clinical features such as necrotizing
vasculitis, granuloma formation in the upper and
lower respiratory tract and glomerulonephritis.
However, evidence for the causal link between
these phenomena is still circumstantial, despite
efforts to demonstrate notably the contribution
of ANCA to vascular and glomerular lesions.
When dissecting the mechanisms that result
in the generation of the disorder WG it may be
helpful to distinguish between an initiator or
trigger phase of the disease and an effector
phase, in which the actual vascular damage
ensues. Obviously, due to our restricted insight
into the course of the disease, the borders
between these two phases are vague and
mechanisms bridging the two phases are
probably present.
The current thesis is focused on
pathophysiologic factors and mechanisms
involved in the trigger phase of the disease and
the events following this phase. The starting
point of this thesis is the cunent concept that,
while genetic determinants create a background
that may favor development of WG,
environmental factors are needed to trigger
pathological processes. Among these
environmental factors, bacterial infections, in
particular with Staphylococcus aureus, have
received special attention. Chronic
staphylococcal carriage in WG patients is not
only significantly higher than in healthy
individuals, but this bacterial agent has been
shown to be a risk factor for disease relapses.
Moreover, various clinical studies assessing the
efficacy of the antibiotic co-trimoxazole in WG
have reported on its capacity to reduce the
frequency of disease relapses and to induce
partial or complete remission, underscoring the
potential role of a bacterial infection in this
disease.
Central to this thesis is the postulate that J.
aureus and its superantigens (SAg) are
implicated in the pathophysiology of WG. We
have focused on SAg because these molecules
are known as strong immunostimulators, in
particular of T cells. In view of the disturbed
immune balance in WG and the presence of
autoimmunity, it is conceivable that bacterial
SAg may be responsible for exaggerated
activation of T cells, resulting in the creation of
an appropriate costimulatory milieu for the
production of ANCA.
The thesis has been organized in two parts,
the first being dedicatedto S. aureus and its SAg
as risk factors for disease relapse in WG, while
the second part deals with aspects of T cell
activation, expansion and c1'tokine production in
the context of SAg or WG-associated
autoantigens as stimulatory agents. Furthermore,
the experimental chapters are preceded by
extensive reviews of the implication of bacterial
SAg in vasculitides in general, and in WG in
particular (chapter 2) and of the various (and
yet unexplored) mechanisms by which S. aureus
may be involved in the pathophysiology of WG
(chapter 8). Since these respective reviews also
present detailed discussion of the experimental
chapters, the present summary will present a
synopsis ofthe studies carried out in the context
ofthis thesis.
PART ONE: S. aureus and its SAg: Risk
factors in WG
S. aureus carriage is not eradicated by co-
trimoxazole: Possible stealth strategy
Various clinical studies have demonstrated a
beneficial effect of treatment of WG patients
with the antibiotic co-trimoxazole. This effect
consisted in a reduction in the number ofdisease
relapses associated with treatment and the
attainment of partial or complete remission.
However, a direct effect of co-trimoxazole on
the eradication of S. aureus has not been shown.
In chapter 3 we addressed the hypothesis that
co-trimoxazole radicates S. aureus carriage in
WG patients. We took advantage of the fact that
frequently, after antibiotic treatment is
discontinued, S. aureus is detected again in these
patients. Thus, we postulated that staphylococcal
strains acquired after antibiotic treatment are
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genetically different from strains carried prior to
treatment, indicating that existing bacteria had
been eradicated by the antibiotic co-trimoxazole.
Relatedness between staphylococcal strains
isolated before, during and after treatment with
co-trimoxazole was assessed by genetic
fingerprinting using a random amplified
polymorphic DNA (RAPD) method.
Our study shows that, in most of the patients
analyzed, staphylococcal strains isolated at
various time points before, during and after
tre"lment with co-trimoxazole are genetically
identical, suggesting that the antibiotic was
ineificacious in eradicating carriage of the
bacterium. One of the interpretations that may be
relevant for further investigation is that
antibiotic treatment may induce the formation of
staphylococcal small colony variants, which are
able to survive in endothelial cells. This stealth
strategy may enable S. aureus to elude detection
as well as assaults by the immune system or
antibiotics. Moreover, we suggest that the
concept of co-trimoxazole efficacy in WG being
due to its immunosuppressive properties rather
than its antibiotic action. mav deserve
reevaluation.
St ap hy loco cc al toxic-shock-sy ndro me-toxi n 1
(TSST-1): Riskfactor in l(G
Staphylococcal superantigens (SAg), among
which the enterotoxins A-E (SEA-SEE), the
toxic-shock-syndrome-toxin-l (TSST-l) and the
exfoliative toxins A and B (ETA, ETB) have
been postulated to be implicated in the
pathogenesis of various autoimmune disorders
on account of their strong immunostimulatory
capacity. In WG we have previously shown that
S. aureus strains carrying genes for SEA, SEC,
TSST-I and ETA are present. In chapter 4 we
have assessed the relative risk of WG patients
carrying SAg-positive S. aureus to develop
disease exacerbations.
This retrospective, longitudinal study, in
which we detected and typed SAg genes by
PCR, documents for the first time pattems of
SAg caniage in a large cohort of patients and a
defined clinical setting. We show that the
staphylococcal SAg genes sea, sec, eta and tsst-
-1 are particularly frequent in WG. Furthermore,
we show that the presence of a SAg-positive ,9.
aureus strain, irrespective ofthe type of SAg, is
not a risk factor for the development of disease
exacerbations. However, a subset of S. aureus
strains, namely those carrying the tsst-1 gene,
constitute a significant risk factor for relapse.
Previous studies strongly suggest that TSST-
I is involved in the pathogenesis ofanother form
of vasculitis, Kawasaki disease. In this disorder,
the association between the presence ofTSST-I
and activation of T cells, resulting in expansion
of TSST-I responsive T cell subsets has been
demonstrated. Thus, this SAg may deserve
further attention in the context of WG.
PART TWO: T cell activation in WG:
Association with super- ant autoantigens
T cells in ll/G are chronically activated
In WG the immune balance is disturbed
resulting in autoimmunity. Cellular, i.e. T cell
immunity is thought to play a role in the
pathology of the disorder, one of its important
tasks being to provide costimulatory help for the
production of ANCA. It is conceivable that
excessive stimulation of T cells, for example by
extemal factors such as bacterial agents, may
promote increased production of ANCA, thus
contributing to disease exacerbations. In chapter
5 we have investigated the activation status of
peripheral blood T cells from WG patients in
relation to disease activity. Cellular and soluble
activation markers (CD25, sCD25 and HLA-
DR) were assessed by FACS or ELISA.
We show that T cell activation, expressed as
the percentage of T cells expressing activation
markers, is significantly increased in WG
patients during both active disease and complete
remission, as compared to healthy individuals.
Our findings suggest that a persisting
stimulatory factor may be responsible for the
chronic activation of T cells. We postulate that
this factor may be a bacterial SAg.
The presence of SAg-positive S. aureus in l{G
is not associated with T cell expansions
Taking the postulate of the previous chapter as a
starting point, namely that staphylococcal SAg
may be responsible for persistent activation ofT
cells in WG, in chapter 6 we investigated the
Summary
association between the presence of SAg-
positive S. aureus and T cell expansions in WG.
The interaction of a SAg with a T cell is
mediated by T cell receptor V-beta chains
encoded by particular V-beta gene families, and
results in proliferation of the respective T cell
subset. Thus, detection of T cell expansions, in
conjunction with the concomitant detection of
the corresponding SAg constitutes a strong
indication of T-cell stimulation by that specific
SAg. In a cross-sectional and a longitudinal
study we measured expansions of T cell subsets
expressing SAg-reactive T cell receptor V-beta
chains by FACS and detected SAg genes in S
aureus strains by PCR.
Although present significantly more
frequently than in healthy individuals, T cell
expansions were not associated with the
presence ofthe corresponding SAg. This finding
suggests that a factor other than SAg may cause
persistent T cell activation, observed in the
previous chapter. Moreover, this finding is
consistent with that of chapter 4, in which we
showed that, except for TSST-1, SAg were not a
risk factor for disease exacerbation in WG.
Unfortunately, in the present study only few
staphylococcal strains were positive for TSST-l
and thus it was not possible to investigate the
relation between this particular SAg, T cell
expansions and disease activity in more detail.
I'his study suggests that a causal link between
staphylococcal SAg and T cell activation in WG
is either not present or not detectable.
The autoantigens proteinase 3 und
myeloperoxidase induce a Th2 cytokine milieu
and T cell proliferation in vitro
Whereas in the previous chapters we addressed
the role of SAg, whose immunostimulatory
potential virtually equals that of mitogens, in
WG, in chapter 7 we focused our attention on
the potential of the WG-associated autoantigens
proteinase 3 (PR3) and myeloperoxidase (MPO)
to elicit T cell proliferation and cltokine
production in vitro. T cell proliferation was used
as an indicator for the capacity of these
autoantigens to detect a population of
autoreactive T cells in the peripheral blood.
Cytokine production in vivo after stimulation
with the autoantigens was investigated for the
first time in this study with the aim of obtaining
insight into the possible effects of these
autoantigens in vivo. Although both autoantigens
are localized in granules of polymorphonuclear
cells, they can be shed as a consequence of
activation or apoptosis of these cells. Apart from
their proteolytic and toxic activity, and from
their ability to induce production of
autoantibodies (ANCA), it is conceivable that
PR3 and MPO may as well elicit cytokine
production by other cell types from the
peripheral blood.
We stimulated peripheral blood mononuclear
cells from vasculitis patients with either PR3 or
MPO, as well as control stimuli. Both
autoantigens provoked proliferation of CD4 T
cells from individual patients, but also from
healthy individuals, suggesting that, apart from
potential activation of autospecific T cells,
cross-reaction with a-specific T cell subsets
takes place. Both autoantigens, but especially
PR3, induced a TH2 cytokine milieu,
characterized by high production of IL-10 and
low production of IFN-y. Moreover, we also
detected high production oflL-6.
Building on in vivo and in vitro data
available on the relation between T cell function,
cytokine pattems and disease activity in WG, we
speculate that PR3 can act as a modulator of
cytokine milieu in vasculitis patients and healthy
individuals. Under non-pathologic conditions
(i.e. in healthy individuals and quiescent
vasculitis patients), the effects of the pro-
inflammatory cytokine IL-6, which is triggered
by PR3, are counter-acted by IL-10, likewise
produced upon stimulation with PR3. In this
context PR3 is released in low amounts by
occasional activation of PMN. Under pathologic
conditions (patients with active PR3-ANCA
associated vasculitis), strong activation of PMN
by a pro-inflammatory cy'tokine milieu, in
conjunction with the presence of ANCA, results
in high release of PR3. Moreover, increased
production of IL-6 by endothelial cells has been
documented during active disease. Furthermore,
IL-10 production in active generalized vasculitic
disease was shown to be significantly lower than
in localized vasculitic disease. Thus, it could be
speculated that autoimmune and pro-
inflammatory mechanisms, triggered by PR3 and
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supported by ANCA, cannot be sufficiently
counteracted by IL-I0.
Outlook
Although we were not able to confirm a link
between staphylococcal SAg, T cell activation
and disease activity in WG, we have raised a
number of questions with regard to the role of
SAg and T cells in this form of vasculitis, which
may deserve further investigation. We have
shown that among staphylococcal SAg, TSST-l
is a risk factor for disease exacerbation in WG(chapter 4). Since treatment of WG patients with
co-trimoxazole does not lead to eradication ofS.
aureus (chapter 3), new means may need to
sought for monitoring S. aureus strains
producing TSST-1. The mechanism by which
this particular SAg may aflect the course of
disease remains unknown, since we found that
the presence of SAg is not associated with
activation and proliferation ofperipheral blood T
cells rn vlvo (chapter 6). However, persistent T
cell activation is present in WG patients with
WG, even during complete remission (chapter
5). It remains to be established which triggers
are responsible for persistent T cell activation.
The autoantigens PR3 and MpO, which are
present in the circulation of WG patients, elicit
moderate T cell stimulation and proliferation ir
vitro (chapter 7), suggesting that the high
numbers of activated T cells that are detectable
in vivo cannot be exclusively accounted for by
autoantigenic stimulation. Cytokines that are
produced by PBL invitro, upon stimulation with
the autoantigens PR3 or MPO (chapter 7) may
be partly responsible for "bystander" T cell
activation in vivo. Moreover, it is conceivable
that in vivo, complex interaction of various
stimuli may skew the immunologic balance
towards T cell activation. In this scenario, ,S.
aureus may play an important, though yet
unidentified role. Chapter 8 offers an extensive
overview over the possible directions that
studies into the role of S. aureus in WG mav
take. However, as has been suggested at various
points and places in this thesis, a major
challenge for future research will be to find out
in how far studies in patients will be able to
provide the answers we seek concerning
pathophysiologic mechanisms
